TCGA database investigations about the survival probability (SP) related to the PLIN1-5, FTH1, TFR1, and FPN gene expression in samples derived from patients suffering with bladder, breast, low-grade glioma, lung, and prostate cancers (Figure 5—figure supplement 1) provided some evidences in accordance with our results. This evidence concerns the gene FTH1 and prostate carcinoma.